The adult mouse prostate has a seemingly endless capacity for regeneration, and sonic hedgehog (SHH) signaling has been implicated in this stem cell-driven process. However, it is not clear whether SHH acts on the epithelium or stromal cells that secrete factors required for epithelial expansion. Because little is known about stromal stem cells compared with their epithelial counterparts, we used in vivo mouse genetics tools to characterize four prostate stromal subtypes and their stem cells. Using knockin reporter alleles, we uncovered that SHH signals from prostate basal epithelial cells to adjacent stromal cells. Furthermore, the SHH target gene Gli1 is preferentially expressed in subepithelial fibroblast-like cells, one of four prostate stromal subtypes and the subtype closest to the epithelial source of SHH. Using Genetic Inducible Fate Mapping to mark adult Gli1-or Smooth muscle actinexpressing cells and follow their fate during regeneration, we uncovered that Gli1-expressing cells exhibit long-term self-renewal capacity during multiple rounds of androgen-mediated regeneration after castration-induced involution, and depleted smooth muscle cells are mainly replenished by preexisting smooth muscle cells. Based on our Genetic Inducible Fate Mapping studies, we propose a model where SHH signals to multiple stromal stem cells, which are largely unipotent in vivo.
genetic fate mapping | mesenchymal lineage analysis | smooth muscle | Gli1 expression I n self-renewing organs, sonic hedgehog (SHH) signaling regulates adult stem cells, including neural stem cells in the forebrain (1, 2) and stem cells in the hair follicle (3, 4) . However, it is unclear whether SHH signaling also regulates stem cells in normally quiescent organs, such as the prostate. Because the murine prostate can maintain its size after 15 rounds of castration-induced involution and androgen-mediated regeneration (5, 6) , at least the epithelial compartment is driven by stem cells. During regeneration, both the epithelium and stroma must be replenished, possibly by separate stem cells. Given that stem cells likely maintain tissue homeostasis and that their deregulation can result in diseases, it is important that dormant adult stromal stem cells in the prostate are identified.
The prostate consists of epithelial ducts made up of three cell types (basal, luminal, and neuroendocrine) surrounded by stromal tissue mainly made up of smooth muscle cells (SMCs) and interstitial fibroblasts. In mouse, the prostatic ducts resemble tree-like structures, and each duct has a proximal region that connects to the urethra. Multiple studies have shown that the proximal region is enriched for epithelial stem cells, with a high capacity to expand in vitro and reconstitute prostate tissue when mixed with embryonic urogenital sinus mesenchyme and grafted under the kidney capsule (6) (7) (8) . In vivo Genetic Inducible Fate Mapping (GIFM) studies further have shown that luminal and basal cells are mainly generated by lineage-restricted unipotent stem cells during regeneration in adult mouse prostate (9) (10) (11) . However, whether there is a separate source of stem cells to replenish the stromal compartment and whether they are unipotent in vivo during regeneration have not been addressed. Given that stromal cells play an essential role in maintaining the epithelium during prostate development (12) and modify prostate benign and malignant disease progression (13, 14) , it is critical that the cellular processes underlying regeneration of the stromal compartment be determined.
In mammals, the HH ligands act through multiple transmembrane proteins, including smoothened (SMO) (15, 16) . SMO activation promotes the formation of GLI2 and GLI3 activators, which induce expression of target genes, including a third Gli gene Gli1. Because Gli1 transcription is dependent on GLI2 and GLI3 activators, Gli1 expression is a sensitive readout of high-level HH signaling (17, 18) . GLI1 functions as a feed-forward activator of the HH signaling pathway, but Gli1 is dispensable for mouse development, including development of the prostate (17, 19, 20) .
Shh expression diminishes postnatally in the mouse prostate, but it is maintained at low levels throughout adulthood (21, 22) . During embryogenesis, Shh is expressed by urogenital sinus epithelium, and Gli1 is expressed in adjacent mesenchyme, indicating unidirectional signaling from the epithelium to the mesenchyme (22) . Shh is required for prostate development within the tissue and to stimulate androgen production (22) (23) (24) , and interestingly, SHH signaling exerts stage-specific effects in the developing prostate (21, 25, 26) . The cell types that are responsive to SHH signaling in the adult prostate are currently Significance Sonic hedgehog (SHH) signaling regulates adult stem cells in many self-renewing organs. However, whether SHH also regulates adult stem cells in tissues like the prostate is unclear. Improving therapy for prostate diseases, including benign prostatic hyperplasia and prostate cancer, will require a better understanding of the key signaling pathways that regulate prostate homeostasis and regeneration. We show that SHH signals from basal epithelial cells to the surrounding stroma in the adult prostate. Moreover, SHH responding cells repopulate the stroma and exhibit long-term self-renewal capacity during multiple rounds of involution and regeneration. Furthermore, we identified four stromal subtypes and present evidence for a model in which the three ductal stromal subtypes are maintained largely by distinct unipotent stem/progenitor cells.
unclear. One hypothesis is that SHH signals to rare epithelial stem cells in the adult prostate to maintain tissue homeostasis (27) . Consistent with this hypothesis, application of SMO inhibitors during regeneration was found to impair regeneration (27) . However, because the cell type responding to SHH was not addressed, it is equally possible that SHH signals to stromal stem cells in a paracrine fashion and that stromal stem cells repopulate the stroma during regeneration. The stroma, in turn, gives a reciprocal signal to regulate the growth of the epithelium. The existence of prostate stromal stem cells was suggested by an in vitro study, where cultured primary stromal cells from benign prostatic hyperplasia (BPH) tissues showed a high proliferative potential and can differentiate into smooth muscle cells, osteocytes, and adipocytes (28) . It is unknown where such cells are located in vivo and whether they are responsive to SHH signaling.
By analyzing the SHH signaling machinery in the adult mouse prostate at single-cell resolution, we uncovered that Shh is expressed exclusively by the epithelium and that Gli1 is expressed exclusively by the stroma. Moreover, we found that cells labeled by Gli1-GIFM survive androgen deprivation, and the labeled smooth muscle cells expand in the nonproximal regions during one round of regeneration. Sma-GIFM studies also uncovered that regenerated smooth muscle cells are predominantly derived from preexisting smooth muscle cells. Thus, in the adult prostate stroma, regeneration is likely achieved by multiple unipotent stem cells, which are responsive to SHH signaling during homeostasis.
Results

SHH Signals from
Basal Epithelial Cells to the Stroma. To address whether the paracrine relationship of SHH signaling in the embryo (22) is preserved in the adult, we analyzed knockin reporter mice expressing lacZ or Gfp from the Shh and Gli genes. Strikingly, in the adult dorsal prostate (DP), we found that Shh was expressed in most basal epithelial cells based on the distribution of β-gal enzyme product of lacZ (bGAL+) in Shh lacZ/+ mice (29) and double fluorescent immunohistochemical (FIHC) staining with the basal marker cytokeratin 5 (CK5) ( Fig. 1 A and B) . Interestingly, a subset of luminal cells exclusively in the most proximal region of the prostatic ducts (immediately adjacent to the urethra) also expressed bGAL but at a low level compared with basal cells (Fig. S1 ). Using Gli1 lacZ/+ mice to identify cells experiencing high-level HH signaling, we found that all bGAL+ cells were positive for a panstromal marker CD34 antigen (30) and negative for CK5 and the panepithelial marker EPCAM ( 
;Gli1
Gfp/+ mice and indeed, found that bGAL+ and GFP+ cells belong to mutually exclusive populations (Fig. S1 ). Therefore, in the adult prostate, basal epithelial cells secrete SHH, and stromal cells respond to it.
We next analyzed expression of the other two GLI transcriptional effectors of HH signaling. Using Gli2 lacZ/+ mice (31), we found that, similar to Gli1, expression of the main activator was restricted to the stroma, although a greater percentage of stromal cells seemed to express Gli2 than Gli1. Double FIHC staining confirmed that all bGAL+ cells were negative for CK5 and EPCAM and positive for CD34 ( Fig. 1 E and F and Fig. S1 ). In contrast, the major repressor of the pathway, GLI3, was found to be expressed in basal epithelial cells in addition to stromal cells using Gli3 lacZ/+ (4) prostates ( Fig. 1 G and H).
Gli1 Expression Is Enriched in Subepithelial Stromal Cells.
We next determined what stromal cell type expresses Gli1. In addition to SMCs and interstitial fibroblasts, an additional subepithelial fibroblast-like cell has been reported in the rat prostate (32, 33) . We characterized the prostate stroma by FIHC labeling with the SMC marker α-smooth muscle actin (SMA) and panstromal marker CD34. Interestingly, we identified four molecularly and spatially distinct stromal subtypes: subepithelial cells (CD34+ and SMA− located between the basement membrane and SMCs), SMCs (CD34+ and SMA+), wrapping cells (CD34+ and SMA− tightly associated with the outer surface of the SMCs), and interstitial fibroblasts (CD34+ and SMA− located between the ducts) ( Fig. 2 A and B and Fig. S2 ). Thus, three stromal subtypes (subepithelial, SMC, and wrapping) constitute the ductal wall. Subepithelial cells and wrapping cells are fibroblastlike cells, because they are positive for CD34 and negative for SMC markers, including SMA, calponin, and smooth muscle myosin heavy chain ( Fig. S2 and Movie S1).
To determine whether Gli1 is preferentially expressed in a particular prostate ductal stromal subtype, we compared the proportion of bGAL+ cells in each subtype in DPs of Gli1 lacZ/+ mice with the proportion of each ductal stromal subtype. The proximal regions of the ducts and the remaining nonproximal regions (intermediate and distal) of the ducts were analyzed separately, because cells in the distal region of ducts preferentially die during involution (34) and epithelial stem cells are enriched in proximal regions (6) . Proximal regions of ducts were defined as having three or more layers of SMCs and situated outside the urethra. Ducts in the nonproximal regions had less than three layers of SMCs. The proportion of bGAL+ subepithelial cells was significantly higher than the proportion of CD34+ subepithelial cells in both regions of the prostate (proximal: 45.3 ± 2.2% vs. 17.1 ± 2.6%, respectively, n = 3 mice, P < 0.001; nonproximal: 26.6 ± 3.5% vs. 10.8 ± 2.7%, respectively, P < 0.01) (Fig. 2 C and D) . Conversely, the proportion of bGAL+ SMCs was lower than the proportion of CD34+ SMCs in both regions (proximal: 43.3 ± 3.3% vs. 69.9 ± 3.6%, respectively, P < 0.001; nonproximal: 53.2 ± 2.8% vs. 71.8 ± 3.2%, respectively, P < 0.01). In contrast, the proportion of bGAL+ wrapping cells was similar to the proportion of CD34+ wrapping cells (proximal: 11.4 ± 4.2% vs. 13.0 ± 1.1%, P > 0.05, respectively; nonproximal: 20.3 ± 2.7% vs. 17.5 ± 0.8%, respectively, P > 0.05). Thus, Gli1 is preferentially expressed by the stromal ductal subtype in closest proximity to the epithelial source of SHH (subepithelial cells).
Gli1-Expressing Cells and Their Progeny Expand During Regeneration
After Castration-Induced Involution. In self-renewing adult tissues, our previous studies using in vivo GIFM showed that Gli1-expressing cells are quiescent stem cells that are maintained for the life of the mouse and give rise to transit-amplifying cells that expand and produce olfactory bulb interneurons (2) or hair follicle epithelium (4). We, therefore, used a similar approach to test whether Gli1-expressing cells in the adult prostate are maintained and replenish the stroma. A prerequisite for such a study is the presence of cell turnover in the stroma of the adult prostate. Previous studies found evidence for cell death in the stroma of the ventral prostate using TUNEL (34) and EM (35) . Because our study is focused on the DP that has the greatest amount of stroma, we performed TUNEL staining on DP sections 7 d after castration. We found evidence for cell death in all three ductal stromal subtypes during involution, with more evidence in nonproximal regions (proximal: 8.4% of subepithelial cells, 1.5% of SMCs, and 14.6% of wrapping cells; nonproximal: 15.3% of subepithelial cells, 5.7% of SMCs, and 17.4% of wrapping cells) (Fig. S3) . Next, we examined the extent of cell proliferation in the three stromal subtypes in the DP 3 d into regeneration and found that the three stromal subtypes displayed proliferation, with more distally (proximal: 6.9% of subepithelial cells, 1.4% of SMCs, and 1.6% of wrapping cells; nonproximal: 10.5% of subepithelial cells, 1.5% of SMCs, and 3.0% of wrapping cells) (Fig. S3) . Thus, stromal cells in the DP undergo extensive turnover during involution/regeneration (I/R).
Adult Gli1-expressing cells were marked and fate mapped by administering Tamoxifen to Gli1
CreER/+ ; R26 lacZ/lacZ males, and the population of cells marked by Gli1-GIFM was compared in prostates of mice that had or had not undergone I/R (Fig. 3A) . The dose of Tamoxifen was adjusted such that only a few cells per section were initially labeled (defined as 5 d after Tamoxifen treatment and referred to as 5 d non-I/R). Significantly, the percentage of the prostate ductal area labeled after one round of I/R was ∼13-fold higher than in 5 d non-I/R controls (19.1 ± 4.5% vs. 1.4 ± 0.4%, P < 0.01) (Fig. 3 B, D, and F) . Moreover, cells marked by Gli1-GIFM were restricted to the stroma and did not contribute to the epithelium (Fig. 3D) , which was confirmed by double FIHC labeling of YFP and CD34 in Gli1
CreER/+ ; R26 Yfp/Yfp prostates (Fig. S4) . Thus, HH signaling does not induce Gli1 transcription in rare epithelial stem cells; instead, it preferentially signals to stromal cells that can repopulate the prostatic stroma after I/R.
To examine the rate of cell turnover in intact homeostatic prostates, we compared non-I/R animals that were killed 5 d (5 d non-I/R) or 5 wk (5 wk non-I/R) after Tamoxifen administration. We found a trend to an increase, albeit not significant, in labeled area from 5 d to 5 wk non-I/R (1.4 ± 0.4% vs. 5.7 ± 1.3%, P > 0.05) (Fig. 3 B, C, and F) . However, the X-GAL+ area in I/Rx1 significantly expanded approximately threefold compared with 5 wk non-I/R (19.1 ± 4.5% vs. 5.7 ± 1.3%, P < 0.05) (Fig. 3 C, D, and F) .
To study the long-term self-renewal capacity of cells marked by Gli1-GIFM, we subjected Gli1
CreER/+ ; R26 lacZ/lacZ mice to three rounds of I/R; we found that the labeled cells persisted and that the percentage of labeled area was similar to the percentage of labeled area of I/Rx1 (17.6 ± 3.1%, P > 0.05) (Fig. 3 D-F) . This result shows that the cells marked by Gli1-GIFM can maintain a steady cell population over a period of extensive cell turnover. To further test this conclusion, we subjected mice to 10 and 12 rounds of I/R, and the cells marked by Gli1-GIFM still persisted (Fig. S4) , indicating that Gli1-expressing cells include stromal stem/progenitor cells that have the capacity for longterm self-renewal.
Our Gli1-GIFM results, which show an expansion of Gli1-expressing cells after I/R, could mean that either Gli1 is preferentially expressed in stromal stem/progenitor cells or all stromal cells can expand the stroma. To distinguish between these possibilities, we randomly marked stromal cells using an R26
CreER/lacZ allele (epithelial cells were also marked but excluded from the quantification). Interestingly, we found that randomly marked prostate stromal cells did not expand significantly in prostates that had undergone one round of I/R compared with 5 d non-I/R control DPs (1.9 ± 0.8% vs. 3.1 ± 2.8%, P > 0.05) (Fig. S5) . This result indicates that most randomly marked stromal cells can, at best, maintain the prostate stroma. In sharp contrast, Gli1-expressing cells preferentially expand the prostatic stroma during the first round of I/R.
Gli1-Expressing Cells Preferentially Expand the SMCs in the Nonproximal
Regions of Prostatic Ducts During Regeneration. Given that Gli1 marks stromal stem/progenitor cells, we examined which specific subtypes are marked with Gli1-GIFM after regeneration using Gli1
CreER/+ ; R26 Yfp/Yfp mice. In the proximal regions of prostatic ducts, both the cell number and the proportion of each YFP+ subtype were not significantly different between I/Rx1 and 5 wk non-I/R prostates (Fig. 4D) . Interestingly, in the nonproximal regions, we found that the number of SMCs marked by Gli1-GIFM was increased nearly threefold in I/Rx1 DPs compared with 5 wk non-I/R DPs (349 ± 90 vs. 136 ± 19 cells/mm 2 of SMA+ area, P < 0.001) (Fig. 4F) . In contrast, the number of subepithelial cells and wrapping cells did not change significantly. The total number of labeled YFP+ cells increased approximately twofold in I/Rx1 DPs compared with in 5 wk non-I/R DPs (544 ± 105 vs. 256 ± 15 cells/mm 2 SMA+ area, P < 0.05). The approximately threefold increase in X-GAL area (above) is likely caused by the larger cell size of the SMC subtype of stroma and its preferential expansion after regeneration. In conclusion, SMCs marked by Gli1-GIFM preferentially expand only in the nonproximal regions of prostatic ducts after I/R, whereas subepithelial and wrapping cells are maintained.
Because we observed different levels of cell death in the three ductal stromal subtypes 7 d into involution, we examined the distribution of stromal subtypes marked by Gli1-GIFM in Gli1
CreER/+ ;
R26
Yfp/Yfp DPs 14 d after castration (end of I). Significantly, the percentage of labeled SMCs among all three labeled subtypes was decreased in the end of I DPs (31.8 ± 4.8% vs. 53.3 ± 7.3% of total YFP+ cells, P < 0.05) (Fig. 4 D and E) , indicating that labeled SMCs are preferentially depleted over the full course of involution. In contrast, the percentage of labeled subepithelial cells and wrapping cells did not change significantly. Finally, both the number and the proportion of labeled SMCs were greatly increased in I/Rx1 DPs compared with end of I DPs (349 ± 90 vs. 65 ± 11 cells/mm 2 SMA+ area, P < 0.001; 62.3 ± 5.7% vs. 31.8 ± 4.8%, P < 0.001).
Smooth Muscle Cells Depleted After Castration Are Replenished by
Preexisting Smooth Muscle Cells. Based on our Gli1-GIFM analysis, Gli1 is preferentially expressed in stromal stem/progenitor cells that expand SMCs during regeneration. Because there are three distinct ductal stromal subtypes, we tested whether the generation of new SMCs during regeneration is because of expansion of Sma-expressing cells or one of the other two subtypes acting as multipotent stem cells. An Sma-CreER BAC transgenic line (36) that specifically labels SMCs was used in GIFM studies. We reasoned that, if SMCs (SMA+) are generated from nonSMCs (SMA−), namely subepithelial cells or wrapping cells, then the cell population marked by Sma-GIFM should be gradually diluted out after multiple rounds of regeneration. If, however, SMCs are generated from preexisting SMCs, then Sma-GIFM will result in persistent labeling after multiple rounds of I/R. We first verified whether the Sma-CreER line specifically labels SMA+ cells in the prostate. We found that, in Sma-CreER/+;R26 tdTomato/+ mice administered a moderate dose of Tamoxifen, almost all tdTomato+ cells were also positive for SMA, with less than three cells per section of DP being SMA− 5 wk after Tamoxifen administration (Fig. S6) . We labeled the majority of smooth muscle by administering a high dose of Tamoxifen to Sma-CreER/+;R26 lacZ/+ mice and subjected the mice to one or six rounds of I/R. Interestingly, the labeling was similar, if not greater, after six rounds of I/R, and it was similar after one round of I/R compared with 5 wk postTamoxifen (Fig. 5) . Furthermore, the great majority of cells marked by Sma-GIFM were SMA+ (Fig. S6) . These results indicate that depleted SMCs are mainly replenished by preexisting SMA+ cells during I/R. Because very few SMA− cells were labeled after one round of I/R, SMA+ cells primarily, if not exclusively, give rise to SMCs. proximal and (G) nonproximal ductal regions after 5 wk non-I/R, at the end of I, and after I/Rx1. Data are presented as mean ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001 by ANOVA; 4,599 YFP+ cells were counted from three mice. Each data point represents one animal.
Discussion
By using powerful mouse genetics tools, we have characterized key components of the canonical SHH signaling pathway at single-cell resolution in the adult mouse prostate and shown that Gli1 marks stromal stem/progenitor cells that have long-term self-renewal capacity and repopulate three ductal stromal subtypes after many rounds of I/R. Moreover, using in vivo GIFM, we found that HH-responding cells do not expand the epithelium during regeneration, suggesting that high-level HH signaling does not regulate epithelial stem cells in the adult mouse prostate during homeostasis. Furthermore, SMCs are mainly regenerated by preexisting SMA+ cells. By extrapolation and based on the spatial separation of stromal subtypes, we propose a model where each stromal subtype is primarily maintained by its own unipotent stem/progenitor cells, which are responsive to SHH signaling during homeostasis in the adult prostate (Fig. 6) .
We identified four stromal subtypes in the adult prostate based on their marker protein profile and position. Interestingly, Gli1 expression is enriched in subepithelial stromal cells. This finding might reflect the fact that subepithelial cells are closest to a source of SHH (basal cells). During prostate development in the mouse, a thin layer of connective tissue (termed lamina propria) is located between the uroepithelium and muscularis mucosa (37) . Additional studies are needed to decipher whether subepithelial cells are derived from cells in the lamina propria, because they have a similar location. Furthermore, we found that each stromal subtype is likely replenished by its own unipotent stem/progenitor cells, a finding that parallels what has recently been shown for the two major epithelial subtypes of the prostate (9-11). Moreover, SMCs marked by Gli1-GIFM are preferentially depleted during involution and expand during regeneration. Interestingly, this finding was observed only in the nonproximal regions of the ducts. Although one explanation could be that a higher cell turnover is detected in the nonproximal regions than the proximal regions, another possibility is that cells migrate from proximal to distal as they regenerate the prostate, a model previously proposed for epithelial stem cells (6) . When tools are available in the future to differentially fate map proximal versus distal cells, such studies will shed light on whether there is a cellular hierarchy along the proximal-distal axis.
We found that, in the adult prostate, Gli1, Gli2, and Gli3 are expressed by stromal cells. Interestingly, Shh and Gli3 are coexpressed in the basal cells, but because Gli1 is not expressed by these cells, basal cells seem to either not be permissive to HH signaling or undergo low-level signaling that is not sufficient to activate Gli1. Therefore, GLI3 likely serves as a transcriptional repressor in basal cells. It is possible that, under certain experimental or disease conditions, an increase in SHH ligand leads to a decrease in GLI3 repressor and/or production of a GLI3 activator (18) , which could result in expression of genes that are normally suppressed by GLI3 repressor. Consistent with the idea that increased SHH could result in prostate cancer, overexpression of SHH ligand by electroporation of the adult mouse prostate was found to result in prostate cancer in 90 d (38) . In contrast, overexpression of a constitutively active form of SMO in the postnatal prostate epithelium does not lead to increased proliferation or cancer after 12 mo (39). One possible explanation for these seemingly opposite conclusions is that, because overexpression of SHH ligand could affect both the stroma and the epithelium, a deregulation of HH signaling in both compartments is required to initiate prostate cancer.
Stromal cells play a critical role in altering many epithelial disease states. In the prostate, ablation of the TGF-β type II receptor in a subset of fibroblasts can promote epithelial tumorigenesis (40) (41) (42) . Also, overexpression of FGF10 in embryonic urogenital sinus mesenchyme promotes cancer in adult dissociated prostate epithelial cells grafted under the kidney capsule (43) . Furthermore, in human prostate cancer, the extent of reactive stroma correlates with disease severity and can be used as a prognostic indicator for disease-free survival (44) . As well, prostate stromal stem cells have been proposed to contribute to the pathogenesis of BPH in some instances (45) . In light of our finding that SHH signals to unipotent stromal stem/progenitor cells, it is important to explore whether increasing HH signaling in prostate stromal stem cells leads to overgrowth of the stroma and whether paracrine signaling then alters the epithelium. In this regard, identification of HH target genes in prostate stroma would then help elucidate how abnormal stromal-epithelial interactions can contribute to BPH and prostate cancer, which is currently incurable at its advanced stage. castration. I/R mice were killed 2 wk after androgen replenishment. Mouse husbandry and all experiments were performed in accordance with Memorial Sloan-Kettering Cancer Center Institutional Animal Care and Use Committee-approved protocols.
Tissue Processing and Staining. Prostates were harvested and dissected in cold PBS, and they were fixed in 4% (vol/vol) paraformaldehyde at 4°C for 20 min (for X-GAL) or overnight (for FIHC). Prostates were embedded in frozen optimum cutting temperature (OCT) compound (VWR) and sectioned at 12 μm. Sections of the dorsal prostates were used for all analysis. For immunostaining, cryosections were stained with the following primary antibodies: bGAL (ab9361; Abcam), CK5 (PRB-160P; Covance), CK8 (TROMA-I; DSHB), EPCAM (14-6773; eBioscience), SMA (F3777; Sigma), CD34 (14-0341; eBioscience), GFP/YFP (A-11122; Invitrogen), calponin (ab46794; Abcam), smooth muscle myosin heavy chain (ab53219; Abcam), and laminin (ab11575; Abcam). Secondary antibodies for double labeling were donkey antispecies conjugated with Alexa Fluor 488 or 555 (Molecular Probes). Nuclei were counterstained with DAPI. The Click-it EdU assay with Alexa Fluor 647 (C10340; Invitrogen) was used according to the manufacturer's protocol. TUNEL staining was carried our according to the Roche Applied Science protocol. X-GAL staining was according to standard protocols. Additional details are in SI Materials and Methods.
Quantification. To quantify the area of cells expressing LacZ, 10× mosaic photographs of three region-matched dorsal prostate sections were taken from each male, and the X-GAL+ area and total ductal wall area (excluding the interstitial area and lumen) were measured using Stereo Investigator (MBF Bioscience). To quantify the YFP+ or EdU+ cells, 20× mosaic photographs of at least three region-matched dorsal prostate sections were taken from each male, and positive cells were counted manually using Stereo Investigator. At least three mice were analyzed for each group in each experiment. Data are presented as mean ± SEM. Statistical analysis was performed using GraphPad Prism version 6.0.
